Submitted by lills on September 21, 2018 - 13:26
A recent article featured on HealthLeaders focused on the ways that cost-effectiveness analysis and value-based healthcare are interestecting and the important insights that they provide for physcians and administrative leaders.
Submitted by lills on August 9, 2018 - 15:13
When ReACH Director Joel Tsevat, MD, MPH joined the faculty at UT Health San Antonio and Dell Medical School at UT Austin in the summer of 2017 he was fascinated by the emphasis on value-based health care in terms of providing care and teaching value-based concepts to students and residents. This fascination led him to ask "how does value-based health care differ from traditional cost-effectiveness analysis?" That question is explored in a recently published paper in the Annals of Internal Medicine.
Submitted by lills on August 9, 2018 - 12:47
A recently released editorial by Founding and Former ReACH Director Barbara J. Turner, MD, MSEd in the Annals of Internal Medicine highlighted the persistant compensation disparities between men and women in academic medicine.
Submitted by lills on September 11, 2017 - 18:13
On Tuesday, August 29th, ReACH Director, Dr. Barbara J. Turner MD, MSEd, Dr. Hope Hubbard MD, an assistant professor of gastroenterology at UT Health San Antonio and Ms. Brenda Westbrooks, a patient screened and cured of hepatitis C through a program at the ReACH Center were featured on the Texas Public Radio program The Source.
Submitted by lills on July 28, 2017 - 17:32
On World Hepatitis Day (July 28th), Dr. Barbara J. Turner, the Director of the Center for Research to Advance Community Health (ReACH) was featured on Texas Public Radio discussing the importance of hepatitis C screening for baby boomers (those born between 1945 and 1960).
Submitted by lills on July 27, 2017 - 18:15
July 28 is World Hepatitis Day, and ReACH Center director Barbara J. Turner MD, MSEd., has a message for the generation most affected by hepatitis C, the baby boomers. Her mantra is the age-old adage: An ounce is prevention is worth a pound of cure.
Submitted by lills on June 30, 2017 - 19:19
Hepatocellular Carcinoma (HCC) is the 9th leading cause of cancer-related death in the US and is one of the few cancers with an increasing incidence and mortality rate. Texas has the second highest HCC rate in the country and HCC is the fastest growing cancer in the state. The ReACH Center and UT Southwestern Medical Center through the support of the Cancer Prevention Research Institute of Texas (CPRIT) have partnered on the Screen Treat or Prevent Hepatocellular Carcinoma (STOP HCC) initiative which aims to reduce HCC incidence and mortality in Texas by implementing an evidence-based hepatitis c virus (HCV) screening and treatment program for low-income populations in primary care settings across South Texas and the Dallas regions.
Submitted by lills on March 31, 2017 - 17:01
On Friday, March 31st, Dr. Barbara J. Turner, the Director of the Center for Research to Advance Community Health (ReACH) was featured on the Texas Public Radio show Texas Standard to discuss a recently published study that looks at how much the Hispanic community knows about chronic pain.
Submitted by lills on March 31, 2017 - 10:14
Hispanics and other minorities are more likely to receive poor quality of care for chronic pain. A new survey of Hispanics’ knowledge about chronic pain reveals that, even with the painkiller-related deaths of celebrities such as Prince and Heath Ledger, most know little about chronic pain and its care, leaving them vulnerable to repeat the dangerous painkiller cycle.
Submitted by lills on January 25, 2017 - 19:58
ReACH Director, Barbara J. Turner MD, MSED was featured in a Huffington Post article published January 23, 2017 that highlights the importance of raising awareness about hepatitis C screening.
Pages
